Bringing plant-based veterinary vaccines to market: Managing regulatory and commercial hurdles

Biotechnology Advances

Volumn 33, Issue 8, 2015, Pages 1572-1581

  MacDonald, Jacqueline ^a   Doshi, Ketan ^b   Dussault, Marike ^c   Hall, J Christopher ^d,e   Holbrook, Larry ^b   Jones, Ginny ^f   Kaldis, Angelo ^a   Klima, Cassidy L ^a   Macdonald, Phil ^g   McAllister, Tim ^a   McLean, Michael D ^d   Potter, Andrew ^h   Richman, Alex ^a   Shearer, Heather ^g   Yarosh, Oksana ^g   Yoo, Han Sang ⁱ   Topp, Edward ^a   Menassa, Rima ^a  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^b Box 19A RRNo5   (Canada)

^c ZOETIS   (United States)

^d PlantForm Corp   (Canada)

^e UNIVERSITY OF GUELPH   (Canada)

^f Elanco Canada Ltd   (Canada)

^g CANADIAN FOOD INSPECTION AGENCY   (Canada)

^h UNIVERSITY OF SASKATCHEWAN   (Canada)

ⁱ Seoul National University   (South Korea)

Author keywords

Antibody; Financing; Freedom to operate; Immunotherapeutic; Intellectual property; Molecular farming; Recombinant vaccine; Scale up

Indexed keywords

ANTIBODIES; COMMERCE; INTELLECTUAL PROPERTY; INTERNATIONAL COOPERATION; LOSSES; SOCIETIES AND INSTITUTIONS; VACCINES;

FINANCING; FREEDOM TO OPERATE; IMMUNOTHERAPEUTIC; MOLECULAR FARMING; RECOMBINANT VACCINES; SCALE-UP;

DISEASES; VACCINES;

ANIMALIA;

ANTIBODY; COMMERCIALIZATION; DISEASE CONTROL; ECONOMIC IMPACT; FINANCIAL PROVISION; INTELLECTUAL PROPERTY RIGHTS; KNOWLEDGE; MANUFACTURING; PLANT COMMUNITY; PUBLIC HEALTH; RECOMBINATION; VACCINE;

RECOMBINANT VACCINE;

ANIMAL; ANIMAL DISEASES; CANADA; ECONOMICS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PLANT;

ANIMAL DISEASES; ANIMALS; CANADA; HUMANS; PLANTS; VACCINES, SYNTHETIC;

EID: 84939857064     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2015.07.007     Document Type: Review

References (76)

1. APVMA Factsheet - about the APVMA [Internet] [cited 2014 Mar 28]. Retrieved from:. http://www.apvma.gov.au/publications/fact_sheets/docs/about_apvma.pdf.
2. APVMA Pesticides and veterinary residues [Internet] [cited 2014 Sept 29]. Retrieved from:. http://apvma.gov.au/node/10806.
3. Bennett N., Miles S.A. Second in command: the misunderstood role of the chief operating officer. Harv. Bus. Rev. 2006, 84:5.
4. Biodesign Institute Blueprint for the development of plant-derived vaccines for the poor in developing countries: intellectual property considerations [Internet] [cited 2014 Aug 15]. Retrieved from:. http://www.biodesign.asu.edu/assets/pdfs/idv-provacs/WHO-Blueprint.pdf.
5. BIS List of 90 products under mandatory certification [Internet] [cited 2014 Aug 14]. Retrieved from:. http://www.bis.org.in/cert/man.pdf.
6. Bock R., Warzecha H. Solar-powered factories for new vaccines and antibiotics. Trends Biotechnol. 2010, 28:246-252.
7. CFIA Directive 94-08: Assessment criteria for determining environmental safety of plants with novel traits [Internet] [updated 2014 Apr 9; cited 2014 Oct 6]. Retrieved from:. http://www.inspection.gc.ca/plants/plants-with-novel-traits/applicants/directive-94-08/eng/1304475469806/1304475550733.
8. CFIA Veterinary Biologics Guideline 4.5E: licensing requirements for veterinary biologics in Canada [Internet] [updated 2012 Jan 17; cited 2014 Nov 3]. Retrieved from:. http://www.inspection.gc.ca/animals/veterinary-biologics/guidelines-forms/4-5e/eng/1318508906578/1318509047147.
9. CFIA Questions and answers: plant molecular farming [Internet] [updated 2012 May 24; cited 2015 Jul 14]. Retrieved from:. http://www.inspection.gc.ca/plants/plants-with-novel-traits/general-public/pmf/questions-and-answers/eng/1337872933676/1337873040972.
10. CFIA Veterinary biologics: frequently asked questions [Internet] [updated 2013 Apr 16; cited 2014 Aug 15]. Retrieved from:. http://www.inspection.gc.ca/animals/veterinary-biologics/licensed-products/frequently-asked-questions/eng/1318483540758/1320705655744.
11. CFIA "Novelty" and plants with novel traits [Internet] [updated 2014 Jan 6; cited 2014 Jan 29]. Retrieved from:. http://www.inspection.gc.ca/plants/plants-with-novel-traits/general-public/novelty/eng/1338181110010/1338181243773.
12. CFIA Veterinary Biologics Guideline 3.1-1 Guidance for preparation of new product licensing (registration) submissions for veterinary biologics manufactured in Canada [Internet] [updated 2014 Jan 31; cited 2014 Mar 28]. Retrieved from:. http://www.inspection.gc.ca/animals/veterinary-biologics/guidelines-forms/3-1e/3-1-1e/eng/1328588172336/1328588294122.
13. CFIA RG-1 Regulatory Guidance Chapter 2 Section 6: Guidelines for the assessment of novel feeds: plant sources [Internet] [updated 2014 May 16; cited 2014 Aug 14]. Retrieved from:. http://www.inspection.gc.ca/animals/feeds/regulatory-guidance/rg-1/chapter-2/eng/1329298059609/1329298179464?chap=6.
14. CFIA RG-1 Regulatory Guidance Chapter 3 Section 21: Specific registration information by feed type: Veterinary biologics [Internet]. 2014e [updated 2014 Sept 16; cited 2014 Dec 12] Retrieved from:. http://www.inspection.gc.ca/animals/feeds/regulatory-guidance/rg-1/chapter-3/eng/1329319549692/1329439126197?chap=21.
15. CFIA RG-1 Regulatory Guidance Chapter 3 Section 22: Specific registration information by feed type: viable microbials and yeasts [Internet], [updated 2014 Sept 16; cited 2014 Dec 12] Retrieved from:. http://www.inspection.gc.ca/animals/feeds/regulatory-guidance/rg-1/chapter-3/eng/1329319549692/1329439126197?chap=22.
16. CFIA Directive 2000-07: Conducting confined research field trials of plant with novel traits in Canada [Internet] 2015 [updated 2015 Apr 30; cited 2015 Jul 16] Retrieved from:. http://www.inspection.gc.ca/plants/plants-with-novel-traits/applicants/directive-dir2000-07/eng/1304474667559/1304474738697.
17. Chen M., Shelton A., Ye G. Insect-resistant genetically modified rice in China: from research to commercialization. Annu. Rev. Entemol. 2011, 56:81-101.
18. Chenault Chamberlin K.D. Deployment: regulations and steps to commercialization. Transgenic Crop Plants Volume 2: Utilization and Biosafety 2010, 391-410. Springer-Verlag, Berlin. C. Kole, C.H. Michler, A.G. Abbott, T.C. Hall (Eds.).
19. Choudhary B., Gheysen G., Buysse J., van der Meer P., Burssens S. Regulatory options for genetically modified crops in India. Plant Biotechnol. J. 2014, 12:135-146.
20. Curtiss R., Cardineau G.A. inventors; Washington University, assignee. Oral immunization by transgenic plants. United States patent US 5679880 1997, Oct 21.
21. DAFF 2013. Information about importing plant based animal feed [Internet], [updated 2013 Jun 14; cited 2014 Aug 13] Retrieved from:. http://www.daff.gov.au/biosecurity/import/plant-products/information-about-importing-plant-based-animal-feed.
22. Canadian Environmental Protection Act, 1999. S.C. 1999, c. 33 (Last amended Oct 25, 2013).
23. European Commission 2015. Press release: More freedom for member states to decide on the GMOs use for food & feed [Internet], [updated 2015 Apr 22; cited 2015 Jul 16] Retrieved from:. http://europa.eu/rapid/press-release_IP-15-4777_en.htm.
24. European Parliament and the Council of the European Union, 2015.Directive (EU) 2015/412 of the European Parliament and of the Council of 11 amending Directive 2001/18/EC as regards the possibility for the Member States to restrict or prohibit the cultivation of genetically modified organisms (GMOs) in their territory. Off. J. Eur. Union March 2015, L68:1-8.
25. European Parliament and the Council of the European Union, 2009.Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 laying down community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council. Off. J. Eur. Union May 2009, L152:11-22.
26. Everett K.M., Dickey L., Parsons J., Loranger R., Wingate V. Development of a plant-made pharmaceutical production platform. Bioprocess Int. 2012, 10:16-25.
27. FDA FDA's role in animal health [Internet] [updated 2014 Jun 13; cited 2014 Sept 29]. Retrieved from:. http://www.fda.gov/animalveterinary/resourcesforyou/animalhealthliteracy/ucm374203.htm.
28. Fischer R., Schillberg S., Hellwig S., Twyman R.M., Drossard J. GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol. Adv. 2012, 30(2):434-439.
29. Fisheries and Oceans Canada 2007. CSAS proceedings series 2006/036: Proceedings of the expert panel meeting on the potential risks associated with horizontal gene transfer from novel aquatic organisms [Internet], [cited 2014 Oct 08] Retrieved from:. http://www.dfo-mpo.gc.ca/Library/327123.pdf.
30. Fisheries and Oceans Canada 2014. Frequently asked questions (is DFO responsible for genetically modified aquatic plants?) [Internet], [updated 2014 Mar 14; cited 2014 Oct 7] Retrieved from:. http://www.dfo-mpo.gc.ca/Science/biotech/abgrds-srdbfa/faq-eng.htm.
31. GAQSIQ 2007. Mission [Internet], [cited 2014 Sept 29] Retrieved from:. http://english.aqsiq.gov.cn/AboutAQSIQ/Mission/.
32. Health Canada Canadian Animal Health Products Regulatory Advisory Committee (CAHPRAC) - Terms of Reference [Internet] [updated 2013 Jan 16; cited 2014 Dec 12]. Retrieved from:. http://www.hc-sc.gc.ca/dhp-mps/consultation/vet/com/cahprac-ccrpsa/tor-mandat-eng.php.
33. Higgins M.C., Gulati R. Stacking the deck: the effects of top management backgrounds on investor decisions. Strateg. Manage. J. 2006, 27:1-25.
34. Huang T.-K., McDonald K.A. Bioreactor systems for in vitro production of foreign proteins using plant cell cultures. Biotechnol. Adv. 2012, 30:398-409.
35. IFAH Europe Factsheet: Animal vaccines: development, registration and production [Internet] [cited 2014 Aug 14]. Retrieved from:. http://www.bft-online.de/fileadmin/bft/aktuelles/IEvaccstate_final__2_.pdf.
36. Jacob S.S., Cherian S., Sumithra T.G., Raina O.K., Sankar M. Edible vaccines against veterinary parasitic diseases-current status and future prospects. Vaccine 2013, 31:1879-1885.
37. Joensuu J.J., Conley A.J., Lienemann M., Brandle J.E., Linder M.B., Menassa R. Hydrophobin fusions for high-level transient protein expression and purification in Nicotiana benthamiana. Plant Physiol. 2010, 152:622-633.
38. Khan I., Twyman R.M., Arcalis E., Stoger E. Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol. J. 2012, 7:1099-1108.
39. Kirk D.D., McIntosh K., Walmsley A.M., Peterson R.K.D. Risk analysis for plant-made vaccines. Transgenic Res. 2005, 14:449-462.
40. Kolotilin I., Kaldis A., Devriendt B., Joensuu J., Cox E., Menassa R. Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco. PLoS ONE 2012, 7:e42405.
41. Kolotilin I., Topp E., Cox E., Devriendt B., Conrad U., Joensuu J., Stöger E., Warzecha H., McAllister T., McLean M.D., Hall J.C., Menassa R. Plant-based solutions for veterinary immunotherapeutics and prophylactics. Vet. Res. 2014, 45:117.
42. Krattiger A., Mahoney R.T. Specific IP issues with molecular pharming: case study of plant-derived vaccines 2007, 1809-1817. MIHR; and Davis, U.S.A.: PIPRA, Oxford, U.K. A. Krattiger, R.T. Mahoney, L. Nelsen (Eds.).
43. Kwon K.-C., Verma D., Singh N.D., Herzog R., Daniell H. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv. Drug Deliv. Rev. 2013, 65:782-799.
44. Macdonald P. Developing workable regulatory frameworks for the environmental release of transgenic plants. Collect. Biosaf. Rev. 2012, 6:126-159.
45. MAPA Strategic Management Office Strategic Plan 2006-2015, 2nd edition [Internet] [cited 2014 Aug 13]. Retrieved from:. http://www.agricultura.gov.br/arq_editor/file/4039_strategic_plan_f.pdf.
46. Matthews L., Reeve R., Gally D.L., Low J.C., Woolhouse M.E.J., McAteer S.P., et al. Predicting the public health benefit of vaccinating cattle against Escherichia coli O157. PNAS 2013, 110:16265-16270.
47. Miralpeix B., Sabalza M., Twyman R.M., Capell T., Christou P. Strategic patent analysis in plant biotechnology: terpenoid indole alkaloid metabolic engineering as a case study. Plant Biotechnol. J. 2014, 12:117-134.
48. MOA 2009. Main Functions of Veterinary Bureau [Internet], [updated 2009 Jun 25; cited 2014 Aug 11] Retrieved from:. http://english.agri.gov.cn/aboutmoa/departments/201301/t20130115_9515.htm.
49. MOHFW 2011. Food safety and standards (contaminants, toxins and residues) regulations [Internet], [cited 29 Sept 2014] Retrieved from:. http://www.fssai.gov.in/Portals/0/Pdf/Food%20safety%20and%20standards%20(contaminats,%20toxins%20and%20residues)%20regulation,%202011.pdf.
50. MOHFW 2005. The drugs and cosmetics acts and rules, as amended up to the 30th of June, 2005 [Internet], [cited 2014 Aug 13] Retrieved from:. http://apps.who.int/medicinedocs/documents/s20107en/s20107en.pdf.
51. OECD 2014. Consensus documents for the work on harmonisation of regulatory oversight in biotechnology [Internet], [cited 2014 Aug 15] Retrieved from:. http://www.oecd.org/env/ehs/biotrack/consensusdocumentsfortheworkonharmonisationofregulatoryoversightinbiotechnology.htm.
52. OGTR Handbook on the regulation of gene technology in Australia: a user's guide to the Gene Technology Act 2000 and related legislation [Internet]. [cited 2014 Aug 12]. http://[cited%202014%20Aug%2012].%20Retrieved%20from:%20http://www.svhm.org.au/research/governance/Documents/handbook[1].pdf.
53. Paul M., Ma J.K.-C. Plant-made pharmaceuticals: leading products and production platforms. Biotechnol. Appl. Biochem. 2011, 58:58-67.
54. Pelosi A., Shepherd R., Walmsley A.M. Delivery of plant-made vaccines and therapeutics. Biotechnol. Adv. 2012, 30:440-448.
55. Phan H.T., Floss D.M., Conrad U. Veterinary vaccines from transgenic plants: highlights of two decades of research and a promising example. Curr. Pharm. Des. 2013, 19:5601-5611.
56. Rivera A.L., Gomez-Lim M., Fernandez F., Loske A.M. Physical methods for plant transformation. Phys. Life Rev. 2012, 9:308-345.
57. Rybicki E.P. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010, 8(5):620-637.
58. Rybicki E.P., Chikwamba R., Koch M., Rhodes J.I., Groenewald J.-H. Plant-made therapeutics: an emerging platform in South Africa. Biotechnol. Adv. 2012, 30:449-459.
59. Scotti N., Rigano M.M., Cardi T. Production of foreign proteins using plastid transformation. Biotechnol. Adv. 2012, 30:387-397.
60. SENASA Dirección de Agroquímicos, Prod Veterinarios y Alimentos: Misión y acciones [Internet] [updated 2010 Dec 1; cited 2014 Aug 13]. Retrieved from:. http://www.senasa.gov.ar/contenido.php?to=n&in=618&io=2423.
61. Sirko A., Vanek T., Gora-Sochacka A., Redkiewicz P. Recombinant cytokines from plants. Int. J. Mol. Sci. 2011, 12:3536-3552.
62. Sparrow P., Broer I., Hood E.E., Eversole K., Hartung F., Schiemann J. Risk assessment and regulation of molecular farming: a comparison between Europe and US. Curr. Pharm. Des. 2013, 19:5513-5530.
63. Statistics Canada Canada's beef industry and BSE [Internet] [updated 2006 Jun 28; cited 2014 Jan 31]. Retrieved from:. http://www41.statcan.gc.ca/2006/0920/ceb0920_001-eng.htm.
64. Tremblay R., Wang D., Jevnikar A.M., Ma S. Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol. Adv. 2010, 28:214-221.
65. Tribe D. Gene technology regulation in Australia: a decade of a federal implementation of a statutory legal code in a context of constituent states taking divergent positions. GM Crops Food 2012, 3:21-29.
66. USDA-APHIS Code of federal regulations, title 7, part 340: introduction of organisms and products altered or produced through genetic engineering which are plant pests or which there is reason to believe are plant pests [Internet] [cited 2014 Aug 14]. Retrieved from:. http://www.ecfr.gov/cgi-bin/text-idx?SID=8b94122d45b8a81aba0619ce6b02e6e9&node=7:5.1.1.1.10&rgn=div5.
67. USDA-APHIS Veterinary Services Memorandum No. 800.211 [Internet] [cited 2014 Aug 14]. Retrieved from:. http://www.aphis.usda.gov/animal_health/vet_biologics/publications/memo_800_211.pdf.
68. USDA-APHIS Veterinary biologics: use and regulation. Program Aid #1713 [Internet] [updated 2013 Feb; cited 2014 Sept 22]. Retrieved from:. http://www.aphis.usda.gov/publications/animal_health/content/printable_version/vet_biologics.pdf.
69. USDA-APHIS Center for Veterinary Biologics policy, evaluation, and licensing reviewer's manual [Internet] [updated 2014 Aug 13; cited 2014 Aug 14]. Retrieved from:. http://www.aphis.usda.gov/wps/portal/aphis/ourfocus/animalhealth/sa_vet_biologics/sa_biologics_regulations/sa_vb_manuals/!ut/p/a0/04_Sj9CPykssy0xPLMnMz0vMAfGjzOK9_D2MDJ0MjDzdgy1dDTz9wtx8LXzMjf09TPQLsh0VAZdihIg!/.
70. USDA-APHIS Federal code of regulations, Title 9, Chapter 1, Subchapter E [Internet] [updated 2014 Dec 10; cited 2014 Dec 12]. Retrieved from:. http://www.ecfr.gov/cgi-bin/text-idx?SID=06b20153c9a9e815637ef237f7dff74e&tpl=/ecfrbrowse/Title09/9CIsubchapE.tpl.
71. Usha R., Rohll J.B., Spall V.E., Shanks M., Maule A.J., Johnson J.E., et al. Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology 1993, 197:366-374.
72. Virdi V., Depicker A. Role of plant expression systems in antibody production for passive immunization. Int. J. Dev. Biol. 2013, 57:587-593.
73. Webb SR, Henry MJ, inventors; Dow Agrosciences Llc., assignee. Vaccine for avian influenza and methods of use. United States patent US 7993655. 2011 Aug 9.
74. Wilken L.R., Nikolov Z.L. Recovery and purification of plant-made recombinant proteins. Biotechnol. Adv. 2012, 30:419-433.
75. Xu J., Dolan M.C., Medrano G., Cramer C.L., Weathers P.J. Green factory: plants as bioproduction platforms for recombinant proteins. Biotechnol. Adv. 2012, 30:1171-1184.
76. Zorn D.M. Here a chief, there a chief: the rise of the CFO in the American firm. Am. Sociol. Rev 2004, 69:345-364.